GRF

Eagle Capital Growth (GRF)

Eagle Capital Growth Fund Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:GRF

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/18	22 : 30	GlobeNewswire Inc.	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/04/04	17 : 00	GlobeNewswire Inc.	Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/03/08	01 : 11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/03/07	02 : 56	Edgar (US Regulatory)	Form N-CSR - Certified Shareholder Report	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/29	01 : 20	Edgar (US Regulatory)	Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/24	06 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/24	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/14	17 : 16	GlobeNewswire Inc.	Grifols announces positive topline phase 3 fibrinogen clinical trial results	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/14	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/14	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2024/02/14	05 : 09	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/12/28	05 : 58	Edgar (US Regulatory)	Form 40-17G - Fidelity Bond [Rule 17G-1(g)]	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/11/15	22 : 00	GlobeNewswire Inc.	Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin Deficiency	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/11/08	06 : 45	Edgar (US Regulatory)	Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/11/06	22 : 00	GlobeNewswire Inc.	GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/10/25	07 : 30	GlobeNewswire Inc.	Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTAD	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/10/14	06 : 30	Business Wire	Eagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in Cash	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/10/03	03 : 30	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/10/03	03 : 16	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/08/31	04 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/08/31	04 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/08/16	06 : 30	Edgar (US Regulatory)	Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/08/16	04 : 45	Edgar (US Regulatory)	Form N-CSRS - Certified Shareholder Report, Semi-Annual	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/08/01	21 : 00	GlobeNewswire Inc.	Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and Analytics	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/05/13	02 : 28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/05/13	01 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/04/20	04 : 25	Edgar (US Regulatory)	Monthly Portfolio Investments Report on Form N-port (public) (nport-p)	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/04/18	23 : 30	PR Newswire (US)	Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/03/17	22 : 40	Edgar (US Regulatory)	Certified Annual Shareholder Report for Management Investment Companies (n-csr)	AMEX:GRF	Eagle Capital Growth Fund Inc
2023/03/01	20 : 42	Edgar (US Regulatory)	Annual Report for Registered Investment Companies (n-cen)	AMEX:GRF	Eagle Capital Growth Fund Inc